A. Eman Et Al. , "The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study," Saudi medical journal , vol.43, no.7, pp.715-722, 2022
Eman, A. Et Al. 2022. The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study. Saudi medical journal , vol.43, no.7 , 715-722.
Eman, A., Balaban, O., Süner, K. Ö., Cırdı, Y., Şahin, F., Demir, G., ... Pekşen, Ö.(2022). The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study. Saudi medical journal , vol.43, no.7, 715-722.
Eman, Ali Et Al. "The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study," Saudi medical journal , vol.43, no.7, 715-722, 2022
Eman, Ali Et Al. "The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study." Saudi medical journal , vol.43, no.7, pp.715-722, 2022
Eman, A. Et Al. (2022) . "The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study." Saudi medical journal , vol.43, no.7, pp.715-722.
@article{article, author={Ali Eman Et Al. }, title={The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study}, journal={Saudi medical journal}, year=2022, pages={715-722} }